BRIEF published on 04/29/2026 at 13:05, 17 days 9 hours ago Cheplapharm prévoit une croissance de son chiffre d'affaires en 2025 Croissance Des Revenus Marge D'EBITDA Stabilité Financière Industrie Pharmaceutique CHEPLAPHARM
BRIEF published on 04/29/2026 at 13:05, 17 days 9 hours ago Cheplapharm Sees Revenue Growth in 2025 Pharmaceutical Industry Revenue Growth EBITDA Margin Financial Stability CHEPLAPHARM
PRESS RELEASE published on 04/29/2026 at 13:00, 17 days 9 hours ago CHEPLAPHARM reports Revenue Growth in the 2025 Financial Year CHEPLAPHARM reports 8.1% revenue growth reaching €1.66 billion in FY2025. EBITDA at €642.8 million with a 38.8% margin. Employee count up 2% to 799 Financial Results EBITDA Revenue Growth CHEPLAPHARM Employee Count
BRIEF published on 02/02/2026 at 15:41, 3 months 14 days ago CHEPLAPHARM's Successful €950m Bond Issuance Refinancing Bond Issuance Financial Strategy Investor Demand CHEPLAPHARM
BRIEF published on 02/02/2026 at 15:41, 3 months 14 days ago L'émission obligataire de 950 millions d'euros de CHEPLAPHARM est un succès Stratégie Financière Emission D'obligations Refinancement Demande Des Investisseurs CHEPLAPHARM
PRESS RELEASE published on 02/02/2026 at 15:36, 3 months 14 days ago Successful Refinancing: CHEPLAPHARM'S new 6.750% Bond multiple times oversubscribed CHEPLAPHARM successfully refinances with new 6.750% bond oversubscribed multiple times, enhancing financial flexibility and maturity profile Refinancing Oversubscribed Financial Flexibility CHEPLAPHARM 6.750% Bond
BRIEF published on 08/27/2025 at 13:34, 8 months 20 days ago CHEPLAPHARM Reports Stable Growth in the First Half of 2025 Pharmaceutical Industry Revenue Growth Transformation Program CHEPLAPHARM Employee Expansion
BRIEF published on 08/27/2025 at 13:34, 8 months 20 days ago CHEPLAPHARM annonce une croissance stable au premier semestre 2025 Croissance Des Revenus Industrie Pharmaceutique CHEPLAPHARM Programme De Transformation Expansion Des Employés
PRESS RELEASE published on 08/27/2025 at 13:29, 8 months 20 days ago CHEPLAPHARM with stable business in the first half of 2025 Cheplapharm AG reports stable business performance in the first half of 2025, with revenue up by 12% and EBITDA up by 24% compared to the second half of 2024 Financial Results Transformation Program Stability Acquisition Opportunities Cheplapharm AG
BRIEF published on 06/26/2025 at 10:36, 10 months 20 days ago L'obligation de 750 millions d'euros de CHEPLAPHARM connaît une forte demande et un prix attractif Obligations Confiance Des Investisseurs Médicaments Flexibilité Financière CHEPLAPHARM
Published on 05/16/2026 at 01:15, 21 hours 40 minutes ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 22 hours 55 minutes ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 23 hours 45 minutes ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 23 hours 55 minutes ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/16/2026 at 16:08, 6 hours 46 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 2 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 1 day 4 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 1 day 7 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 1 day 7 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 1 day 12 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days 13 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 3 days 4 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
